Hyperkinetic Movement Disorder as the First Manifestation of Gaucher Disease Type 3
Objective: Gaucher disease, an autosomal recessive lysosomal storage disorder, is caused by a deficiency of the enzyme glucocerebrosidase. This results in the accumulation of glucosylceramide…How Remote Coaching Enables Engagement in Physical Activity for People with Parkinson’s Disease in Qatar: A Qualitative Study of Participant and Therapist Perspectives
Objective: To explore participant and therapist perspectives on how a culturally adapted remote coaching program supports engagement in physical activity among PwPD in Qatar. Background:…Chinese Expert Consensus and Recommendations on Sensing-guided Deep Brain Stimulation for Parkinson’s Disease: A Modified Delphi Study
Objective: To propose some well-accepted recommendations on sensing-guided deep brain stimulation for Parkinson's Disease. Background: Deep brain stimulation (DBS) has been widely accepted as a well-established neurosurgical…Patient perspectives on meaningful symptoms and disease progression in Parkinson’s Disease (PD): Interim findings from the Patient Endpoint Preference Project (PEPP)
Objective: The Patient Endpoint Preference Project (PEPP) aims to identify and quantify early‑stage PD patients’ priorities around symptoms and their progression using patient‑reported questionnaires. The…STOP-TIC Updates: Strengthening Tourette Treatment Options using TMS to Improve CBIT: A randomized sham-controlled trial
Objective: To determine if accelerated repetitive transcranial magnetic stimulation (rTMS) will augment Comprehensive Behavioral Intervention for Tics (CBIT) for Tourette Syndrome (TS) symptoms. Background: rTMS…Impact of foslevodopa/foscarbidopa infusion on autonomic symptoms in advanced Parkinson’s Disease
Objective: To investigate the impact of continuous subcutaneous foslevodopa/foscarbidopa infusion (CSFLI) on autonomic symptoms in patients with advanced Parkinson’s disease (aPD) Background: CSFLI is a…Remotely acquired speech-based biomarkers and their relation to motor and cognitive functions in Parkinson’s disease
Objective: To evaluate the feasibility and clinical validity of remote, digital speech-based cognitive and speech motor assessments in Parkinson’s disease (PD). Background: Speech in PD…Binge-eating as an Initial Presentation for the Diagnosis of Chorea-acanthocytosis
Objective: - Background: Chorea-acanthocytosis (ChAc) is an autosomal recessive disorder associated with mutations or deletions in the VPS13A gene on chromosome 9q21, which codes for…Translational Target Engagement of HER-096 Demonstrates Concordant Proteostasis and Mitochondrial Modulation in Preclinical Models and Patients with Parkinson’s Disease
Objective: To evaluate translational target engagement of HER-096, a CDNF-derived peptidomimetic, in preclinical models of Parkinson’s disease (PD) and in a Phase 1b clinical study…Late-onset THAP-1 with SCA8 expansion mimicking functional movement disorder, case report.
Objective: - Background: Functional movement disorders (FMD) are characterized by abnormal movements without an identifiable neurological cause. Diagnosis and management of patients with FMD can…
- « Previous Page
- 1
- …
- 175
- 176
- 177
- 178
- 179
- …
- 1942
- Next Page »